Annals ofHepatitis

Volume: 2 - Number: 3 - February 15, 2008

Outstanding

A case for treatinghigh hepatitis B DNA levels prior to startin HIV therapy

ABSTRACT: Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans

ABSTRACT: Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice

ABSTRACT: Report of an International Workshop: Roadmap for Management of Patients Receiving Oral Therapy for Chronic Hepatitis B

Treatment of Hepatitis B e Antigen–Positive Chronic Hepatitis with Telbivudine or Adefovir: A Randomized Trial

HBV pathogenesis in animal models: Recent advances on the role o platelets

ABSTRACT: Viral Hepatitis

ABSTRACT: Treatment extension to 72 weeks of peginterferon and ribavirin in hepatitis c genotype 1-infected slow responders

ABSTRACT: Hepatitis B virus DNA levels at week 4 of lamivudine treatment predict the 5-year ideal response

ABSTRACT: Distinct hepatitis C virus core and F protein quasispecies in tumoral and nontumoral hepatocytes isolated via microdissection

ABSTRACT: Evidence for human leukocyte antigen heterozygote advantage against hepatitis C virus infection

ABSTRACT: Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81 (p 1722-1731)

ABSTRACT: Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: The role of rapid and early virologic response

ABSTRACT: Predictors of treatment in patients with chronic hepatitis C infection - Role of patient versus nonpatient factors

ABSTRACT: Liver disease in adolescents: A cohort study of high-risk individuals

ABSTRACT: Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans

ABSTRACT: Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice

ABSTRACT: Report of an International Workshop: Roadmap for Management of Patients Receiving Oral Therapy for Chronic Hepatitis B

Original Articles

High Cooperativity of the SV40 Major Capsid Protein VP1 in Virus Assembly

Design of extended short hairpin RNAs for HIV-1 inhibition

Long-Term Protection against HBV Chronic Carriage of Gambian Adolescents Vaccinated in Infancy and Immune Response in HBV Booster Trial in Adolescence

A case for treatinghigh hepatitis B DNA levels prior to startin HIV therapy

Characterization of mutation spectra with ultra-deep pyrosequencing: Application to HIV-1 drug resistance

Correlates of Suicidal Ideation and Attempt Among Female Sex Workers in China

Improved silencing properties using small internally segmented interfering RNAs

Poor knowledge – predictor of nonadherence to universal precautions for blood borne pathogens at first level care facilities in Pakistan

Complete suppression of viral gene expression is associated with the onset and progression of lymphoid malignancy: observations in Bovine Leukemia Virus-infected sheep

Impact on and use of an inner-city London Infectious Diseases Department by international migrants: a questionnaire survey

Meningococcal, influenza virus, and hepatitis B virus vaccination coverage level among health care workers in Hajj

Hepatitis B virus (HBV) genotypes in Egyptian pediatric cancer patients with acute and chronic active HBV infection

Down-regulation of SFRP1 as a putative tumor suppressor gene can contribute to human hepatocellular carcinoma

Enantioselectivity of human AMP, dTMP and UMP-CMP kinases

Incidence of cytomegalovirus infection among the general population and pregnant women in the United States

FluGenome: a web tool for genotyping influenza A virus

The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders

Modulating the Expression of Disease Genes with RNA-Based Therapy

Common Genotypes of Hepatitis B virus prevalent in Injecting drug abusers (addicts) of North West Frontier Province of Pakistan

Viral Hepatitis

Treatment of Hepatitis B e Antigen–Positive Chronic Hepatitis with Telbivudine or Adefovir: A Randomized Trial

HBV pathogenesis in animal models: Recent advances on the role o platelets